Testosterone Replacement Therapy, or TRT, was approved by the FDA for treatment of conditions related to deficiency or abscence of endogenous (biologically/bodily produced) testosterone. TRT is also used for conditions associated with primary hypogonadism, or testicular failure -- as well as hypogonadotropic hypogonadism, which is usually a genetic trait inherited from the patient's parents.
There are many TRT drugs currently produced and available on the market -- from gels and patches used on the skin and gums to pills and shots. Some of these drugs were recently linked to cases of heart attack and cardiac death; the FDA announced in January 2014 that it was investigating increased risk of heart attackds, strokes, and cardiac arrest related to use of TRT.
Men using these drugs could be at risk; research has shown that treatments such as AndroGel can result in debilitating side effects. One peer-reviewed study showed that patients using TRT could seriously increse chances of heart attacks or develop cardiovascular issues. Almost 4% of all men over age 60 have used some forme of TRT, and drug companies and manufacturers have marketed the products as a cure for "Low T", claiming that restoring testosterone levels can improve quality of life, cure erectile dysfunction, and even restore memory function.
While the FDA approved teststerone treatments for those suffering deficiencies or absence of testosterone, another study in 2013 revealed tha tnearly 25% of men prescribed TRT had never had their actual testosterone levels checked.
TRT brands that could be harmful:
AndroGel®, Androderm®, Android 10®, Android 25®, Axiron®, Fortesta®, Bio-T-Gel®, Delatestryl®, Depo-Testosterone®, Methyltestosterone®, Striant®, Testim®, Testopel®, Testosterone, Cypionate®, Enanthate®
If you think Testosterone Replacement Therapy has caused harm to your health or have suffered side effects or illness as a result of using TRT, please call us. We may be able to help.
Kathy Brown Law s not associated with, sponsored by or affiliated with The Food and Drug Administration, AbbVie, USA Today, The New England Journal of Medicine, PLOS One or JAMA Internal Medicine.
AndroGel is a registered trademark of AbbVie and is used here only to identify the product in question. Androderm is a registered trademark of Watson and is used here only to identify the product in question. Android 10, Android 25 and Testred are registered trademarks of Valeant Pharmaceuticals International and are used here only to identify the products in question. Axiron is a registered trademark of Eli Lilly and Co. and is used here only to identify the product in question. Delatestry, and Fortesta are registered trademarks of Endo Pharmaceuticals and are used here only to identify the products in question. Methyltestosterone is a registered trademark of Impax Laboratories Inc. and is used here only to identify the product in question. Striant and Testopel are registered trademarks of Actient Pharmaceuticasls LLC and are only used here to identify the product in question. Testim is a registered trademark of Auxilium Pharmaceuticals Inc. and is only used here to identify the product in question. Testosterone Cypionate is produced by Paddock Pharmaceuticals, Sandoz, Mylan Pharmaceuticals, Actavis (formerly known as Watson Pharmaceuticals), Bedford Laboratories, Hikma Pharmaceuticals and Sun Pharmaceutical Industries Ltd. and is only used here to identify the product in question. Testosterone Enanthate is produced by Paddock Pharmaceuticals, Mylan Pharmaceuticals, Actais (formerly known as Watson Pharmaceuticals) and Hikma Pharmaceuticals and is used here only to identify the product in question.